| Product Code: ETC334165 | Publication Date: Aug 2022 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Thailand import trend for mumps vaccine from 2020 to 2024 experienced a significant decline with a compound annual growth rate (CAGR) of -96.97%. This sharp decrease could be attributed to factors such as changes in demand dynamics, market saturation, or shifts in procurement strategies impacting trade performance.

The Thailand Mumps Vaccine Market is a critical component of the country`s healthcare system. Vaccination plays a vital role in preventing the spread of mumps, a contagious viral infection. The Thai government has been proactive in its vaccination programs, ensuring that children and adults receive proper immunization. This market primarily consists of pharmaceutical companies and healthcare providers. The importance of mumps vaccination in preventing outbreaks underscores the significance of this market, which continues to evolve with advancements in vaccine technology and public health initiatives.
The Mumps vaccine market in Thailand is driven by government immunization programs and increasing awareness about the importance of vaccination. Thailand`s healthcare infrastructure has been actively promoting immunization, making Mumps vaccines more accessible to the general population. Outbreaks of Mumps in certain areas have also heightened awareness, encouraging individuals and parents to seek vaccination for themselves and their children.
The Thailand Mumps Vaccine Market faces several challenges. One significant issue is the need for continuous education and awareness campaigns to encourage vaccination. Vaccine hesitancy, fueled by misinformation and concerns about side effects, can hinder immunization efforts. Additionally, ensuring an uninterrupted supply chain for vaccines and maintaining cold chain logistics poses logistical challenges. The government and healthcare authorities need to invest in infrastructure and outreach to address these issues effectively.
The COVID-19 pandemic had a limited direct impact on the Thailand mumps vaccine market, as the demand for vaccines remained steady throughout the crisis. However, the vaccination landscape in Thailand underwent significant changes due to the pandemic. The government and healthcare authorities prioritized the distribution of COVID-19 vaccines, leading to adjustments in the vaccination schedules and priorities. Routine vaccination programs, including mumps vaccines, faced delays and disruptions as healthcare resources were diverted to combat the pandemic. This had potential consequences for public health, as delayed vaccinations could increase the risk of mumps outbreaks. Healthcare providers had to implement safety measures to continue vaccination programs while minimizing COVID-19 transmission.
In the field of vaccines, the Thailand Mumps Vaccine market is led by companies like GlaxoSmithKline plc, Merck & Co., Inc., and Sanofi Pasteur. These pharmaceutical giants are involved in the development and distribution of vaccines, including those for mumps.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Mumps Vaccine Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Mumps Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Mumps Vaccine Market - Industry Life Cycle |
3.4 Thailand Mumps Vaccine Market - Porter's Five Forces |
3.5 Thailand Mumps Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
3.6 Thailand Mumps Vaccine Market Revenues & Volume Share, By Distribution channel, 2022 & 2032F |
4 Thailand Mumps Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Thailand |
4.2.2 Government initiatives to improve immunization coverage |
4.2.3 Rising prevalence of mumps cases in Thailand |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with mumps vaccines |
4.3.3 Vaccine hesitancy among certain population segments |
5 Thailand Mumps Vaccine Market Trends |
6 Thailand Mumps Vaccine Market, By Types |
6.1 Thailand Mumps Vaccine Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Thailand Mumps Vaccine Market Revenues & Volume, By Age Group, 2022-2032F |
6.1.3 Thailand Mumps Vaccine Market Revenues & Volume, By Pediatric, 2022-2032F |
6.1.4 Thailand Mumps Vaccine Market Revenues & Volume, By Adult, 2022-2032F |
6.2 Thailand Mumps Vaccine Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 Thailand Mumps Vaccine Market Revenues & Volume, By Hospitals Pharmacies, 2022-2032F |
6.2.3 Thailand Mumps Vaccine Market Revenues & Volume, By Drug Stores, 2022-2032F |
6.2.4 Thailand Mumps Vaccine Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
7 Thailand Mumps Vaccine Market Import-Export Trade Statistics |
7.1 Thailand Mumps Vaccine Market Export to Major Countries |
7.2 Thailand Mumps Vaccine Market Imports from Major Countries |
8 Thailand Mumps Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rates in Thailand |
8.2 Number of reported mumps cases in the country |
8.3 Percentage of the population receiving booster shots as recommended |
8.4 Public perception and acceptance of mumps vaccination |
8.5 Number of healthcare facilities offering mumps vaccination services |
9 Thailand Mumps Vaccine Market - Opportunity Assessment |
9.1 Thailand Mumps Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
9.2 Thailand Mumps Vaccine Market Opportunity Assessment, By Distribution channel, 2022 & 2032F |
10 Thailand Mumps Vaccine Market - Competitive Landscape |
10.1 Thailand Mumps Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Thailand Mumps Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here